Gazyva 1,000 MG/40 ML vial 40ML
Ended Awarded
- Contract number
- SPE2DR26FQN3W
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,123
Award facts
- Contract value 100% obligated
- $20,122.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $20,122.88 delivery order to AmerisourceBergen Drug Corp for 1,000 mg/40 ml vials of Gazyva, a monoclonal antibody medication used in oncology and hematology treatments. This firm fixed-price contract, issued on October 22, 2025, with an ultimate completion date of November 13, 2025, represents a non-competitive delivery order placed under AmerisourceBergen's existing pharmaceutical supply framework. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will perform fulfillment from its corporate office location.
This delivery order is executed under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement running through December 2026 that enables comprehensive global pharmaceutical support for military healthcare systems. The parent IDC provides a flexible contracting vehicle allowing AmerisourceBergen to supply specialty medications, brand-name and generic pharmaceuticals, and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare customers. As a major pharmaceutical distributor, AmerisourceBergen regularly fulfills competitively awarded delivery orders across DLA's medical supply chain, demonstrating capability to meet federal procurement requirements for critical medication needs.
Quick answers
Who was awarded contract SPE2DR26FQN3W?
SPE2DR26FQN3W was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 22, 2025.
How much is contract SPE2DR26FQN3W worth?
The government has obligated $20,123 on SPE2DR26FQN3W.
Is contract SPE2DR26FQN3W an order under another contract?
Yes. SPE2DR26FQN3W is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQN3W competed?
The extent of competition for SPE2DR26FQN3W was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award